Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments Post published:February 2, 2021 Post category:Press Release
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development Post published:January 19, 2021 Post category:Press Release
Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc. Post published:January 14, 2021 Post category:Press Release
Entheon Biomedical Engages Star Finance GmbH for Investor Relations Post published:January 12, 2021 Post category:Press Release
Entheon Biomedical Engages World Renowned Media Personality DJ Skee, AKA Scott Keeney, as Media Advisor Post published:January 11, 2021 Post category:Press Release
Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC Post published:January 4, 2021 Post category:Press Release
Entheon Biomedical Closes Private Placement Post published:December 26, 2020 Post category:Press Release
Entheon Biomedical Announces Private Placement Post published:December 18, 2020 Post category:Press Release
Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion of Initial DMT Research Drug Batch and Exercise of Warrants Post published:December 9, 2020 Post category:Press Release
Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific Post published:December 4, 2020 Post category:Press Release